Three days after my AMS initiation note, the company confirmed another takeover approach — qualitatively different from the previous five. H.B. Fuller (NYSE: FUL), the US adhesives major, tabled an unsolicited cash proposal on 30 April. Critically, this is a strategic buyer, not financial. Fuller already makes medical adhesives and wants to bolt on AMS’s […]
Keller’s AGM update is reassuringly uneventful — and for a company that has spent recent years rebuilding investor trust on execution, that is exactly the point. Trading in the first four months is described as strong year-on-year and in line with expectations, with North American foundations once again carrying the load. The order book has […]
TA Associates this week confirmed it does not intend to proceed with a formal offer for Advanced Medical Solutions (AMS), bringing the latest private-equity approach to an end. Under Rule 2.8 of the Takeover Code, TA is now restricted from making another offer for six months — but other suitors are not. What is striking […]
A bittersweet moment as I sold about 2 months or so ago. At least good to know that somebody else saw the value in it too. 100% pop in a day, not bad.
Q1 Portfolio Update: Navigating Multiple Compression and Sector Rotation The first quarter was defined by a ruthless recalibration of equity risk premiums. Against a challenging macroeconomic backdrop, capital rotated aggressively out of long-duration growth assets and into businesses offering tangible near-term cash flows, robust balance sheets, and pricing power. The portfolio generated an average total […]
While there is a lot of noise in the market, for those of you who want to buy and hold their positions for a few years, here is a list of my top 10 in alphabetical order. One thing to notice is the large portion of US names, despite me investing in the UK for […]
First of all, Happy New Year to all investors out there. Hope 2026 brings you lots of success. So on to the update for Q4 and a few thoughts on 2025. The porfolio performed reasonably well during Q4, delivering average return of 2.8% vs negative 2.2% for FTSE AIMs and 2.6% for S&P500. A few […]
While I no longer hold them, I still follow them closely for potential entry. Both had reasonable updates(revenue growth more than profitability) as the NIC contributions are starting to bite into these labour intensive sectors. I am keenly following what will come out of the budget as there is significant speculation that there will be […]
Just a short post to comment on the results for Google and Amazon(and Meta, a position which I started building into since the start of the year). I thought all 3 had excellent results(especially google for which I had some reservations(see H1 performance commentary). Overall I think these stocks will have the least amount of […]
A few of the companies would be posting results in the coming weeks(MSI and Volex as well as a couple more on my watchlist that I am building positions in). Hoping for blow out results from MSI in particular as it has been especially quiet from a news perspective. There might be also some strategic […]